MDT

86.81

-0.34%↓

115.29

+0.17%↑

VEEV

156.49

+3.32%↑

HQY

78.14

+0.03%↑

TLRY

6.47

-1.67%↓

MDT

86.81

-0.34%↓

115.29

+0.17%↑

VEEV

156.49

+3.32%↑

HQY

78.14

+0.03%↑

TLRY

6.47

-1.67%↓

MDT

86.81

-0.34%↓

115.29

+0.17%↑

VEEV

156.49

+3.32%↑

HQY

78.14

+0.03%↑

TLRY

6.47

-1.67%↓

MDT

86.81

-0.34%↓

115.29

+0.17%↑

VEEV

156.49

+3.32%↑

HQY

78.14

+0.03%↑

TLRY

6.47

-1.67%↓

MDT

86.81

-0.34%↓

115.29

+0.17%↑

VEEV

156.49

+3.32%↑

HQY

78.14

+0.03%↑

TLRY

6.47

-1.67%↓

Home・Stock List・Celldex Therapeutics Inc

Celldex Therapeutics Inc

Open

SectorHealthcare

32.15 -0.12

Buy Sell

Overview

Share price change

24h

Current

Min

32.08

Max

32.73

Key metrics
By Trading Economics
Income	-14M -81M
Sales	75K 75K
EPS	-1.22
Profit margin	-108,422.667
Employees	198
EBITDA	-7.8M -81M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+69.04% upside

Dividends
By Dow Jones
Next Earnings	6 May 2026

Market Stats
By TradingEconomics
Market Cap	472M 2.1B
Previous open	32.27
Previous close	32.15

News Sentiment

By Acuity

100%

330 / 348 Healthcare

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

18.91 / 20.63 Support & Resistance

Celldex Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

12 Apr 2026, 23:44 UTC

Market Talk

Major News Events

Nikkei Likely to Fall After U.S.-Iran Peace Talks Break Down -- Market Talk

12 Apr 2026, 23:38 UTC

Market Talk

Major News Events

Oil Climbs as U.S.-Iran Peace Talks Fail, U.S. Navy Starts Blockade of Strait of Hormuz -- Market Talk

12 Apr 2026, 23:38 UTC

Market Talk

Australia's Upstream Energy Companies Poised for Consensus Earnings Upgrades -- Market Talk

12 Apr 2026, 23:36 UTC

Market Talk

Major News Events

Gold Falls as Dollar Strengthens After U.S.-Iran Peace Talks Collapse -- Market Talk

12 Apr 2026, 23:31 UTC

Market Talk

A2 Milk's Supply Issues Likely Temporary -- Market Talk

12 Apr 2026, 23:09 UTC

Market Talk

Major News Events

Australian Dollar Hammered by Blockade of Iran Ports -- Market Talk

12 Apr 2026, 23:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 Apr 2026, 23:06 UTC

Market Talk

Australian Dollar Ripe for a Downward Correction -- Market Talk

12 Apr 2026, 22:56 UTC

Major News Events

Spot Gold Falls 1.9% to $4,658.65 per Ounce

12 Apr 2026, 22:54 UTC

Major News Events

Front-Month Brent Crude Oil Futures Rise 7.6% to $102.42 per Barrel

12 Apr 2026, 22:53 UTC

Major News Events

Front-Month WTI Crude Oil Futures Rise 8.3% to $104.56 per Barrel, ICE Data Show

12 Apr 2026, 22:51 UTC

Major News Events

Front-Month Crude Oil Futures Climb After U.S.-Iran Peace Talks Break Down

12 Apr 2026, 22:50 UTC

Market Talk

Major News Events

US Dollar Climbs Amid Broad Risk Off Mood In FX Market -- Market Talk

12 Apr 2026, 22:37 UTC

Market Talk

Major News Events

Australian Dollar Under Fire as Middle East Tensions Ratchet Up Again -- Market Talk

11 Apr 2026, 08:20 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

11 Apr 2026, 08:20 UTC

Market Talk

Health Care Roundup: Market Talk

11 Apr 2026, 08:20 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

11 Apr 2026, 00:00 UTC

Earnings

Acquisitions, Mergers, Takeovers

Big Yachts, Big Bucks -- Barrons.com

10 Apr 2026, 21:55 UTC

Acquisitions, Mergers, Takeovers

Paramount Warrants Are an Underappreciated Aspect of Warner Bros. Deal -- Barrons.com

10 Apr 2026, 21:01 UTC

Earnings

Cango Inc.: Files Annual Report on Form 20-F With SEC

10 Apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

10 Apr 2026, 20:50 UTC

Market Talk

Major News Events

Basic Materials Roundup: Market Talk

10 Apr 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10 Apr 2026, 20:31 UTC

Market Talk

Convenience Store Traffic Slows as Gas Prices Rise -- Market Talk

10 Apr 2026, 20:10 UTC

Acquisitions, Mergers, Takeovers

This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring. -- Barrons.com

10 Apr 2026, 19:15 UTC

Market Talk

Global Energy Roundup: Market Talk

10 Apr 2026, 19:15 UTC

Market Talk

Oil Futures Settle Lower With Focus on U.S.-Iran Talks -- Market Talk

10 Apr 2026, 19:08 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10 Apr 2026, 19:08 UTC

Market Talk

U.S. Natural Gas Futures End Week Lower -- Market Talk

10 Apr 2026, 18:38 UTC

Market Talk

Canada's Job Market Showing Soft Demand, Structural Decline in Supply -- Market Talk

Peer Comparison

Price change

Celldex Therapeutics Inc Forecast

Price Target

By TipRanks

69.04% upside

12 Months Forecast

Average 54.5 USD 69.04%

High 90 USD

Low 24 USD

Based on 11 Wall Street analysts offering 12 month price targets forCelldex Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

11 ratings

Buy

Hold

Sell

Based on 11 analysts giving stock ratings to Celldex Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

18.91 / 20.63Support & Resistance

Recent bullish events outweigh bearish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Celldex Therapeutics Inc

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory, allergic, autoimmune, and other devastating diseases. The company's clinical development programs CDX-0159, a Phase II monoclonal antibody that binds the receptor tyrosine kinase KIT and inhibits its activity. It has research collaboration and license agreements with Yale University. The company was incorporated in 1983 and is headquartered in Hampton, New Jersey.